Therapeutic _'s treatment of the lung bead fungus disease
Treat and have illness coming on and remove the risk factor originally at first, for instance inactive antibiotic, hormone and immune inhibitor. Strengthen the support treatment, strengthen the organism immunological function. Should try hard to remove the inducement related to the fact that a disease happen, for instance: Employ antibiotic of wide table, cortex steroid hormone or patient of immune inhibitor in a large amount for a long time, must consider stopping medicine or decrement; If there are complications such as diabetes and malignant tumour,etc., should give corresponding treatment; Keep the affected part dry, clean.
1, nystatin
Product this can inhibit getting white the intersection of bead and fungus, but difficult to absorb from gastrointestinal tract, suitable for digestive tract infect or suck, treat the respiratory system, infect as atomization only. Take each times 500,000- 100 U Wan inside, one day 3, use together 1-2 weeks.
2, the two sexes mould plain B and ball erythromycin
It has certain results to treat the viscera bead fungus disease to drip that the two are quiet, but toxicity is relatively large, must pay attention to observing. Domestic Mount Lushan mould to have similar curative effect with the two sexes mould plain B while being plain.
3, one gram of mould thiazole
Adult's daily dosage 2- 3g, divide into for 3 times and take orally, uses for 2 weeks continuously.
4, ketone health thiazole
The quantity 200mg of the adult, 1 times a day. Somebody proposes this product 200mgs, it is the same to take once as result once a day on the next day.
5, garlic parenteral solution
20- 40ml, adds the liquid of glucose quietly to drip, once a day, curative effect is relatively satisfied with, toxicity is also little.
6th, shift the factor
Skin note, or take first cyanogen miaow guanidine 300mg orally once on the next day, 4 times a day, can improve the organism cell immunological function, there are benefits on promoting patients and recovering.
|
0 comments:
Post a Comment